Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
94.41 BRL | +20.44% |
|
-2.68% | +38.61% |
07-03 | Regeneron, Sanofi Say Chronic Obstructive Pulmonary Disease Treatment Gains European Approval | MT |
07-03 | Sanofi obtains EU approval for Dupixent | RE |
End-of-day quotes
Sector Bio Therapeutic Drugs
Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
---|---|---|---|---|---|---|
121B | ||||||
25.98B | - | |||||
19.27B | - | |||||
15.99B | ||||||
15.66B | - |